PlainBillCongress, translated.Legislation. Context. Public interest.
H.R.1520 / 116th Congress

Further Extension of Continuing Appropriations Act, 2021

Became Public Law No: 116-246.

Official summary

Version 00 · Introduced in House · Mar 5, 2019

Purple Book Continuity Act of 2019

This bill modifies requirements for the Food and Drug Administration to publish information regarding biological products.

Read the summary on Congress.gov
PlainBill analysis is coming later. This page presents official source data. We have not yet published a PlainBill explanation for this bill.

Who introduced it

Rep. Eshoo, Anna G. [D-CA-18] · D–CA

Committees

  • Health, Education, Labor, and Pensions Committee
  • Energy and Commerce Committee
12 cosponsorship records, including any withdrawals

Actions

A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.

  1. Became Public Law No: 116-246.

  2. Became Public Law No: 116-246.

  3. Signed by President.

  4. Signed by President.

  5. Presented to President.

  6. Presented to President.

  7. Message on Senate action sent to the House.

  8. Senate agreed to the House amendment to the Senate amendment to H.R. 1520 by Voice Vote. (consideration: CR S7923)

  9. Resolving differences -- Senate actions: Senate agreed to the House amendment to the Senate amendment to H.R. 1520 by Voice Vote.

  10. Message on House action received in Senate and at desk: House amendment to Senate amendment.

  11. House agreed to the Senate amendment with an amendment pursuant to the provisions of H.Res. 1271. (consideration: CR H7300; text of amendment in the nature of a substitute: CR H7300)

  12. Message on Senate action sent to the House.

  13. Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S7396-7397)

  14. Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.(text of amendment in the nature of a substitute: CR S7396-7397)

  15. Measure laid before Senate by unanimous consent. (consideration: CR S7396-7397)

  16. Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.

  17. Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.

  18. Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

  19. Motion to reconsider laid on the table Agreed to without objection.

  20. On motion to suspend the rules and pass the bill, as amended Agreed to by recorded vote (2/3 required): 421 - 0 (Roll no. 188). (text: CR H3485-3486)

    House roll call 188 · Individual votes
  21. Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by recorded vote (2/3 required): 421 - 0 (Roll no. 188).(text: CR H3485-3486)

    House roll call 188 · Individual votes
  22. Considered as unfinished business. (consideration: CR H3491-3492)

  23. At the conclusion of debate, the chair put the question on the motion to suspend the rules. Ms. Eshoo objected to the vote on the grounds that a quorum was not present. Further proceedings on the motion were postponed. The point of no quorum was considered as withdrawn.

  24. DEBATE - The House proceeded with forty minutes of debate on H.R. 1520.

  25. Considered under suspension of the rules. (consideration: CR H3485-3486)

  26. Ms. Eshoo moved to suspend the rules and pass the bill, as amended.

  27. Placed on the Union Calendar, Calendar No. 26.

  28. Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-48.

  29. Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-48.

  30. Ordered to be Reported (Amended) by Voice Vote.

  31. Committee Consideration and Mark-up Session Held.

  32. Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .

  33. Subcommittee Consideration and Mark-up Session Held.

  34. Referred to the Subcommittee on Health.

  35. Referred to the House Committee on Energy and Commerce.

  36. Introduced in House

  37. Introduced in House

Bill text & related measures

Text links open the official source. We currently store references to these documents.

Related bills identified by Congress.gov

Source last updated: May 28, 2025. Consult Congress.gov for the current record.

Explore the bill from different angles

Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.

Neutral evidence review

Objective

Analyze H.R.1520 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.

View full prompt & sources
Fairness and public impact

Progressive lens

Examine H.R.1520 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.

View full prompt & sources
Institutions and government scope

Conservative lens

Examine H.R.1520 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.

View full prompt & sources
Individual rights and government power

Liberty lens

Examine H.R.1520 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.

View full prompt & sources